GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

Today
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
JB Chemicals & Pharmaceuticals Ltd
Receipt of Certified copy of Order passed by National Company Law Tribunal, Ahmedabad Bench ("NCLT") regarding the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with ....
M&A ▲ Positive Development LOW RISK
📅 Filed on BSE: 07 Jul 2026, 06:06 PM IST  ·  BSE ID: ece133be-072e-44f7-af6c-2f73a9d6dfc6
View Original BSE Filing (PDF)
💡
In Simple Terms
JB Chemicals got the final court order for its merger with Torrent Pharmaceuticals, making the amalgamation legally complete.
🤖 AI Summary
  • JB Chemicals & Pharmaceuticals Limited received the certified NCLT order for amalgamation on July 7, 2026.
  • The National Company Law Tribunal, Ahmedabad Bench, sanctioned the Scheme of Amalgamation via an order dated July 6, 2026.
  • The amalgamation involves J. B. Chemicals & Pharmaceuticals Limited as the Transferor Company.
  • Torrent Pharmaceuticals Limited is designated as the Transferee Company in the sanctioned Scheme.
  • The Scheme falls under Sections 230 to 232 of the Companies Act, 2013, governing corporate arrangements.
🏢 How This Affects the Company
📈
Business Impact
The amalgamation with Torrent Pharmaceuticals Limited will integrate JB Chemicals' operations, potentially altering its product portfolio and market reach within the pharmaceutical sector.
💰
Financial Impact
The merger structure will lead to a re-evaluation of combined assets, liabilities, and equity, impacting the financial statements of the merged entity.
⚙️
Operational Impact
Integration of JB Chemicals' and Torrent Pharmaceuticals' business functions, including manufacturing, supply chain, and administrative processes, will commence following the legal sanction.
⚠️
Risk Impact
Completion of the amalgamation reduces regulatory and execution risks associated with the merger approval process that were present prior to the NCLT sanction.
👥 What This Means For Shareholders
Action Required
Shareholders of JB Chemicals & Pharmaceuticals Limited are not required to take any immediate action based on this specific filing.
👤
Who Is Affected
Shareholders of J. B. Chemicals & Pharmaceuticals Limited will be affected by the Scheme of Amalgamation as their shares will be exchanged for shares in Torrent Pharmaceuticals Limited, based on the approved scheme terms.
🔍
Management Signal
The management's filing indicates proactive compliance with regulatory requirements and transparency in communicating key steps of the corporate amalgamation process.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Scheme of Amalgamation effective date — check official notification for merger completion.
Exchange ratio announcement — verify terms for JB Chemicals shares into Torrent Pharmaceuticals.
First combined financial results — evaluate performance of the merged entity.
LOW RISK The filing confirms a regulatory approval, reducing uncertainty related to the amalgamation process.
💡 Investor Takeaway
JB Chemicals & Pharmaceuticals Limited received the certified National Company Law Tribunal (NCLT) Order on July 7, 2026, officially sanctioning its Scheme of Amalgamation with Torrent Pharmaceuticals Limited. This confirms the legal completion of the merger approval process.
⚖️ Strengths & Concerns

✅ Positives

  • The receipt of the certified NCLT order formally concludes a significant regulatory phase for the amalgamation, confirming legal sanction.
  • The completion of the amalgamation process enhances clarity regarding the future corporate structure and business integration plans.
📅 Company Track Record
Previous filings indicated the ongoing process for this amalgamation: on July 6, 2026, the NCLT pronounced its final order sanctioning the merger. A corrigendum order was issued on March 25, 2026, publicly clarifying prior details related to the scheme of amalgamation.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the key event disclosed by JB Chemicals & Pharmaceuticals Limited on July 7, 2026?
JB Chemicals & Pharmaceuticals Limited announced the receipt of the certified copy of the Order passed by the National Company Law Tribunal (NCLT), Ahmedabad Bench, regarding its Scheme of Amalgamation with Torrent Pharmaceuticals Limited.
When did the NCLT originally sanction the amalgamation scheme for JB Chemicals?
The Hon’ble National Company Law Tribunal, Ahmedabad Bench, sanctioned the Scheme of Amalgamation via its Order dated July 6, 2026.
Which entities are involved in the Scheme of Amalgamation sanctioned by the NCLT?
The Scheme of Amalgamation involves J. B. Chemicals & Pharmaceuticals Limited as the Transferor Company and Torrent Pharmaceuticals Limited as the Transferee Company.
Under which legal provisions was the Scheme of Amalgamation sanctioned?
The Scheme was sanctioned under the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, read with the Rules framed thereunder.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.